4-123107627-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_145207.3(AFG2A):​c.2340+16922C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.454 in 152,098 control chromosomes in the GnomAD database, including 19,208 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 19208 hom., cov: 33)

Consequence

AFG2A
NM_145207.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.305

Publications

1 publications found
Variant links:
Genes affected
AFG2A (HGNC:18119): (AFG2 AAA ATPase homolog A) This gene encodes a member of the ATPase associated with diverse activities family, whose members are defined by a highly conserved ATPase domain. Members of this family participate in diverse cellular processes that include membrane fusion, DNA replication, microtubule severing, and protein degradation. The protein encoded by this gene has a putative mitochondrial targeting sequence and has been proposed to function in maintenance of mitochondrial function and integrity during mouse spermatogenesis. Allelic variants in this gene have been associated with epilepsy, hearing loss, and cognitive disability syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
AFG2A Gene-Disease associations (from GenCC):
  • microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • syndromic complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_145207.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.605 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_145207.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AFG2A
NM_145207.3
MANE Select
c.2340+16922C>T
intron
N/ANP_660208.2Q8NB90-1
AFG2A
NM_001438322.1
c.2412+16922C>T
intron
N/ANP_001425251.1
AFG2A
NM_001437913.1
c.2409+16922C>T
intron
N/ANP_001424842.1A0A6Q8PGU6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AFG2A
ENST00000274008.5
TSL:1 MANE Select
c.2340+16922C>T
intron
N/AENSP00000274008.3Q8NB90-1
AFG2A
ENST00000675612.1
c.2409+16922C>T
intron
N/AENSP00000502453.1A0A6Q8PGU6
AFG2A
ENST00000905945.1
c.2337+16922C>T
intron
N/AENSP00000576004.1

Frequencies

GnomAD3 genomes
AF:
0.454
AC:
69044
AN:
151980
Hom.:
19207
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.125
Gnomad AMI
AF:
0.759
Gnomad AMR
AF:
0.507
Gnomad ASJ
AF:
0.503
Gnomad EAS
AF:
0.511
Gnomad SAS
AF:
0.320
Gnomad FIN
AF:
0.661
Gnomad MID
AF:
0.358
Gnomad NFE
AF:
0.610
Gnomad OTH
AF:
0.472
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.454
AC:
69053
AN:
152098
Hom.:
19208
Cov.:
33
AF XY:
0.454
AC XY:
33733
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.124
AC:
5159
AN:
41534
American (AMR)
AF:
0.507
AC:
7754
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.503
AC:
1745
AN:
3472
East Asian (EAS)
AF:
0.511
AC:
2622
AN:
5128
South Asian (SAS)
AF:
0.320
AC:
1544
AN:
4822
European-Finnish (FIN)
AF:
0.661
AC:
6996
AN:
10590
Middle Eastern (MID)
AF:
0.357
AC:
105
AN:
294
European-Non Finnish (NFE)
AF:
0.610
AC:
41437
AN:
67954
Other (OTH)
AF:
0.473
AC:
1000
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1620
3240
4860
6480
8100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
596
1192
1788
2384
2980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.533
Hom.:
3016
Bravo
AF:
0.433
Asia WGS
AF:
0.441
AC:
1531
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.3
DANN
Benign
0.16
PhyloP100
0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs307059;
hg19: chr4-124028782;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.